Advances in our understanding of cancer immunology and the mechanisms by which cancer immunotherapies exert their effects have translated into increasingly positive patient outcomes.
The recent successes of immunotherapeutics, particularly immune checkpoint inhibitors, have served to demonstrate the power and potential of immune-based treatment strategies. Now there is a need to build upon what we have learned in order to effectively treat more patients with cancer.
SITC Cancer Immunotherapy CONNECT is your hub for live and online educational opportunities. SITC CONNECT also provides access to all of the latest data in the field of tumor immunology and cancer immunotherapy. Connect to other researchers in the Cancer Immunotherapy CONNECT Open Forum and submit your manuscript to the Journal for ImmunoTherapy of Cancer (JITC) to drive progress in the field.
Please join Bob Ferris, Ezra Cohen and me plus a stellar group of faculty for the 3rd New Horizons in Immunotherapy for Head and Neck Cancer , June 15-16, 2018 in Pittsburgh, PA! ------------------------------ ...
A specificarticle reviewed the literature on efficacy and safety of CTLA-4 and PD-1-blocking antibodies in preexisting autoimmune disorder patients.This Paper suggests, on the basis of evidence, ...
From Parp inhibitors to anti-PD-1 therapies, here we present an overview of the biggest news stories from 2018 ASCO-SITC Clinical Immuno-Oncology Symposium (January 25–27; CA, USA).
Hi Hegel I came across to the following:Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations ...
View More Researcher Resources
In this video, hear SITC Annual Meeting delegates explain the purpose and benefits for joining thousands of their colleagues at the Annual Meeting & Pre-Conference Programs, share how far the science of cancer immunotherapy has progressed and predict where the field is headed. Also, learn about the benefits of becoming a member of SITC.
For more than 30 years the Society for Immunotherapy of Cancer (SITC) has been fighting for treatment and a cure for cancer through research and collaboration. SITC members all over the world are leading the charge against cancer. We’re traveling the globe to meet these thought leaders and demonstrate the crucial work that they’re doing to impact advances in both the science and clinical application of immunotherapy.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com